Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
Title | Homepage - Epics |
Description | Epics Therapeutics About Science News Contact Privacy Partnerships Publications Events Jobs Facebook Twitter EPICS invents medicines EPICS is a drug disco |
Keywords | N/A |
WebSite | epicstherapeutics.com |
Host IP | 193.104.37.112 |
Location | Belgium |
Site | Rank |
US$295,758
Last updated: 2023-05-11 05:37:35
epicstherapeutics.com has Semrush global rank of 35,787,053. epicstherapeutics.com has an estimated worth of US$ 295,758, based on its estimated Ads revenue. epicstherapeutics.com receives approximately 34,126 unique visitors each day. Its web server is located in Belgium, with IP address 193.104.37.112. According to SiteAdvisor, epicstherapeutics.com is safe to visit. |
Purchase/Sale Value | US$295,758 |
Daily Ads Revenue | US$274 |
Monthly Ads Revenue | US$8,191 |
Yearly Ads Revenue | US$98,283 |
Daily Unique Visitors | 2,276 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
epicstherapeutics.com. | A | 1799 | IP: 193.104.37.112 |
epicstherapeutics.com. | NS | 86400 | NS Record: ns2.eurodns.com. |
epicstherapeutics.com. | NS | 86400 | NS Record: ns3.eurodns.com. |
epicstherapeutics.com. | NS | 86400 | NS Record: ns4.eurodns.com. |
epicstherapeutics.com. | NS | 86400 | NS Record: ns1.eurodns.com. |
epicstherapeutics.com. | MX | 3600 | MX Record: 10 mail.epicstherapeutics.com. |
epicstherapeutics.com. | TXT | 3600 | TXT Record: v1f2difqhgce391m8tkjgad9e |
epicstherapeutics.com. | TXT | 3600 | TXT Record: google-site-verification=kkLBbVg5oypgDfvI6FxOgCjwzP4B0dr70yvIbww5GhQ |
epicstherapeutics.com. | TXT | 3600 | TXT Record: v=spf1 mx ip4:193.104.37.0/24 ip4:91.183.139.0/24 ~all |
Epics Therapeutics About Science News Contact Privacy Partnerships Publications Events Jobs Facebook Twitter EPICS invents medicines EPICS is a drug discovery and development company that invents and develops small molecule drugs targeting RNA epigenetic mechanisms involved in cancer development About What’s new at Epics Therapeutics ? Press release EPICS Therapeutics to present compelling in vivo efficacy in oncology with its proprietary METTL3 inhibitor at AACR 2023 11.04.23 Press release EPICS Therapeutics Names Franz Obermayr Ph. D., Chief Executive Officer 31.01.22 Press release EPICS Therapeutics Initiates First-in-Human Studies with EP282, an oral Investigational Drug for the treatment of gastrointestinal inflammatory disorders and cancer 12.01.22 Press release EPICS Therapeutics to Acquire Ogeda former assets, Adding Drug Discovery & Development Capabilities 03.01.19 See all news Barbara Wroblewski Marketing Communication Manager Europe Lorem ipsum dolor sit amet, consectetur |
HTTP/1.1 301 Moved Permanently Date: Thu, 04 Nov 2021 04:19:21 GMT Server: Apache/2.4.10 (Debian) Location: https://www.epicstherapeutics.com/ Content-Type: text/html; charset=iso-8859-1 HTTP/1.1 200 OK Date: Thu, 04 Nov 2021 04:19:21 GMT Server: Apache/2.4.10 (Debian) X-Powered-By: PHP/5.6.40-0+deb8u12 Set-Cookie: PHPSESSID=h2f6hjk9dttud95q294nhhd6g3; path=/ Expires: Thu, 19 Nov 1981 08:52:00 GMT Cache-Control: no-store, no-cache, must-revalidate, post-check=0, pre-check=0 Pragma: no-cache Set-Cookie: sCookieSecurity=deleted; expires=Thu, 01-Jan-1970 00:00:01 GMT; Max-Age=0; path=/ Content-Type: text/html |
Domain Name: EPICSTHERAPEUTICS.COM Registry Domain ID: 2143373304_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.eurodns.com Registrar URL: http://www.EuroDNS.com Updated Date: 2021-07-07T08:02:03Z Creation Date: 2017-07-15T08:18:51Z Registry Expiry Date: 2022-07-15T08:18:51Z Registrar: EuroDNS S.A. Registrar IANA ID: 1052 Registrar Abuse Contact Email: legalservices@eurodns.com Registrar Abuse Contact Phone: +352.27220150 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS1.EURODNS.COM Name Server: NS2.EURODNS.COM Name Server: NS3.EURODNS.COM Name Server: NS4.EURODNS.COM DNSSEC: unsigned >>> Last update of whois database: 2021-10-19T06:45:15Z <<< |